+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

From
From
Virtual Oncology Market - Global Strategic Business Report - Product Thumbnail Image

Virtual Oncology Market - Global Strategic Business Report

  • Report
  • November 2025
  • 364 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Injectable Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • November 2025
  • 386 Pages
  • Global
From
From
Immunotoxins - Global Strategic Business Report - Product Thumbnail Image

Immunotoxins - Global Strategic Business Report

  • Report
  • November 2025
  • 377 Pages
  • Global
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 211 Pages
  • Global
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 287 Pages
  • Global
From
Rituximab - Global Strategic Business Report - Product Thumbnail Image

Rituximab - Global Strategic Business Report

  • Report
  • November 2025
  • 378 Pages
  • Global
From
From
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 396 Pages
  • Global
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 267 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 180 Pages
  • Global
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 488 Pages
  • Global
From
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more